Episode summary
The Big 3: HCA, ISRG, MRNA
Summary
Healthcare was presented as one of the day’s relative bright spots while the broader market sold off sharply. The host and a guest argued that investors were rotating toward defensive areas, with healthcare supported by a flight to safety, a divided government, and long-run demand from an aging population. The three names highlighted were HCA Healthcare, Intuitive Surgical, and Moderna.
For HCA, the guest framed the stock as one of the few sectors still in an uptrend and said the business benefits from the scale of U.S. hospital operations. The technical discussion focused on a recovery that has not yet cleared a major resistance area near 511 to 512, while support was mapped lower around 470 to 492 and near 440. The trade idea was bullish but cautious: a June 17th, 2027 call spread structure using the 500 and 580 strikes.
Intuitive Surgical was described as a way to own healthcare plus technology, with the guest citing third-quarter revenue up 22% to $3 billion and worldwide procedures up 15%. The chart work highlighted a W-shaped bottom, bullish moving-average crossovers, and support around the mid-400s. Moderna was also treated as a long-biased healthcare name, with the guest pointing to a melanoma-related partnership and a chart still inside an upward channel, though below recent highs near 255.
Key takeaways
- The guest said healthcare was one of the only S&P 500 sectors still acting constructively during the selloff.
- HCA was viewed as long-term bullish, but the guest wanted upside exposure with defined risk rather than an outright stock bet.
- Intuitive Surgical’s third-quarter revenue rose 22% to $3 billion, and the guest said worldwide procedures grew 15%.
- Moderna was described as having an uptrend since the beginning of the year despite a pullback from recent highs.
- Rick Ducat said HCA faces resistance around 511 to 512, while Intuitive Surgical has support clustered near the mid-400s.
Notable quotes
“the health care sector has actually been in an uptrend, which is why I put a little bit of on thatpace because tech has been volatile”
“the trend is your friend. this is one of the only trends in the S 5 that is up”
“If you look at their third quarter, revenue climbed 22% to $3 billion”
“we have crossed above all of them and pretty quick succes here”
“Everyone knows as the Covid vaccine, but they also have some cool thingey're e partnership with Keytruda”
Topics
- ai selloff
- healthcare sector stocks
- options trades
- technical analysis
- stock charts
Companies and tickers mentioned
- HCA
- ISRG
- MRNA
- HCA Healthcare
- Intuitive Surgical
- Moderna
Watch the episode
Watch “The Big 3: HCA, ISRG, MRNA” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Schwab Network
-
Jensen Huang Weighs Return as NVDA CEO; Risks & Rewards in 2027 CapEx Trade -
KG: "Shocked" by October Retail Sales; AI Chips Struggle as NVDA Drags -
NVDA Influence Beyond Tech: How Earnings Move VIX, Other Sectors -
The Big 3: SHOP, TMUS, S -
NVDA Earnings, Tighter AI Chip Restrictions to Test SPX Bulls -
How NVDA Earnings Will Move Wall Street; U.S. Tightens AI Chip Exports
Schwab Network, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.